Is currently Chief Financial Officer of Bowen Acquisition Corporation, a Nasdaq-listed SPAC company. Previously, she served as Chief Financial Officer of Keyarch Acquisition Corporation, also a Nasdaq-listed SPAC company, which went successfully from independent IPO in 2022 to De-SPAC IPO in 2024. Prior to SPAC career, Dr. Lu served as Chief Investment Officer of the New Hope Fertility Center in New York, Managing Director and then Chief Operating Officer of China Bridge Capital USA, a PE/VC investment advisory company specialized in innovative technologies. Dr. Lu was also an Executive Director at CIBC World Markets working on corporate securities, a bank regulator and supervisor at the Federal Reserve Bank of New York, a professor of economics at York University in Canada, specializing her teaching and research in Macroeconomics, Institutional Economics, and Econometrics. Dr. Lu holds Ph.D. and M.A. in Economics from Western University in Canada, Graduate Certificate in Economics from People’s University in China, and B.A in World Economy from Fudan University in China.